Daniel Cushing Email

Chief Technology & Development Officer; VP, Development . Carisma Therapeutics

Current Roles

Employees:
145
Revenue:
$28.1M
About
Carisma Therapeutics is pioneering the development of CAR macrophages, a disruptive approach to immunotherapy. Our technology leverages advances in macrophage biology, chimeric antigen receptor engineering and adoptive cellular therapy for the treatment of human disease.
Carisma Therapeutics Address
3675 Market St
Philadelphia, PA
United States
Carisma Therapeutics Email

Past Companies

Carisma TherapeuticsChief Technology & Development Officer; Vice President, Development
Medical & Regulatory Affairs ConsultingManaging Partner
Nuron Biotech Inc.Chief Scientific Officer; Senior Vice President, Research & Development

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.